Search
-
The Ipsos Mobility Report 2026
The Ipsos Mobility Report is a 31-country study which explores consumer attitudes to the future of mobility, public transport and road safety. See how the U.S. compares.
-
Artificial Intelligence: Key insights, data and tables
Here’s what business leaders and policymakers need to know about AI and its uses in entertainment, healthcare, politics and more
-
Experience Perspective: An Ipsos Podcast
An Ipsos podcast series exploring best practices in customer and employee experience strategies, mystery shopping and channel performance.
-
The Ipsos Care-o-Meter: What does America know about vs. what does America care about?
The Ipsos Care-o-Meter asks Americans what they know about vs. what they care about twice every month. From sports to politics, the answers say as much about Americans as they do about the world at large. Here's the latest.
-
Retail, food, and beverage: Essential data and insights
From subscription services and e-commerce to tariffs and boycotts, the ways we shop and spend are in flux. Here’s Ipsos’ top data and analysis on what you need to know.
-
[WEBINAR] Biopharma Dealmaking 2026: Trends, Shifts, and What Comes Next
In this webinar, Ipsos will frame the latest dealmaking trends using recent transactions and market data, followed by a moderated discussion with active investors on what is changing in valuation, deal structures, and decision criteria, and what this means for pharma acquirers and innovator biotechs preparing for partnering conversations.
-
Ipsos Data Drops: How Americans feel about AI shopping agents
Only a third of Americans open to agentic shopping would prefer to use the payment method already on file with a retailer if other options would save money or bring rewards — presenting a new opportunity for payment providers to increase share and disrupt the status quo.
-
Ipsos Data Drops 2026
In 2026, we continue our series of three-minute briefings on what business leaders need to know about today.
-
From Spark to Inferno
How Chinese Biopharma Innovation is Forging the Future of Global Oncology Deal Making.